FDA
approval
· 2012-04-17
FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Teva's glipizide and metformin hydrochloride, a combination medication for type 2 diabetes, indicating an approved a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)